Clariane SEFRA:KO2 +1.62%61 FCF Margin % is 19.30% as of Dec. 2025, which is 185% above its 10-year median of 6.78. GuruFocus rates FRA:KO2 with a GF Score™ of 61/100 and a GF Value™ of €2.46 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 669 Healthcare Providers & Services companies, Clariane SE ranks better than 86.4% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Clariane SE's Free Cash Flow for the
six
months ended in Dec. 2025 was €512 Mil. Clariane SE's Revenue for the
six
months ended in Dec. 2025 was €2,655 Mil. Therefore, Clariane SE's FCF Margin % for the quarter that ended in Dec. 2025 was 19.30%.
The historical rank and industry rank for Clariane SE's FCF Margin % or its related term are showing as below:
FRA:KO2'
s FCF Margin % Range Over the Past 10 Years
Min: 3.38 Med: 6.78 Max: 15.36
Current: 15.36
During the past 13 years, the highest FCF Margin % of Clariane SE was 15.36%. The lowest was 3.38%. And the median was 6.78%.
FRA:KO2's FCF Margin % is ranked better than 86.4% of 669
companies
in the Healthcare Providers & Services industry
Industry Median: 3.39
vs FRA:KO2: 15.36
Clariane SE FCF Margin % Related Terms
Clariane SE FCF Margin % Historical Data
* Premium members only.
The historical data trend for Clariane SE's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Clariane SE's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clariane SE FCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Clariane SE's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Clariane SE's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clariane SE (FRA:KO2) has a FCF Margin % of 19.30% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Clariane SE and its competitors. This is 185% above median its historical median of 6.78. Over the past decade, Clariane SE's FCF Margin % has ranged from 3.38 to 15.36. According to the industry distribution chart, Clariane SE ranks #91 out of 669 companies in the Healthcare Providers & Services industry, placing it in the top 13.6%.
Is Clariane SE's FCF Margin % too high?
Clariane SE's current FCF Margin % of 19.30% is 185% above median its 10-year median of 6.78. Over the past 10 years, this metric has ranged from a low of 3.38 to a high of 15.36. The Healthcare Providers & Services industry median FCF Margin % is 3.39. Clariane SE's value of 19.30% is 469.3% above this industry median. Based on the distribution chart, Clariane SE ranks #91 out of 669 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Clariane SE has a GF Score™ of 61/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clariane SE's FCF Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Clariane SE ranks #91 out of 669 companies for FCF Margin %. This places Clariane SE in the top 14% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 3.39. Clariane SE's value of 19.30% is 469.3% above this benchmark. Historically, Clariane SE's own FCF Margin % has ranged from 3.38 to 15.36 over the past decade. While the company's 10-year median is 6.78 vs. the industry median of 3.39, Clariane SE has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.39, based on 669 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Clariane SE's current FCF Margin % of 19.30% is 469.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Clariane SE and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Clariane SE's current FCF Margin % is 19.30%, which is 185% above median its own 10-year median of 6.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clariane SE stock overvalued right now?
Based on GuruFocus' analysis, Clariane SE (FRA:KO2) is currently considered Significantly Overvalued. The stock's GF Value™ is €2.46, compared to a current price of €4.14 — trading 68.3% above its estimated fair value. The current FCF Margin % is 19.30%, which is 185% above median its 10-year median of 6.78 and 469.3% above the Healthcare Providers & Services industry median of 3.39. Clariane SE's overall GF Score™ is 61/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Clariane SE (FRA:KO2), the current FCF Margin % is 19.30% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Clariane SE (FRA:KO2) Overvalued in 2026?
Based on GuruFocus' analysis, Clariane SE stock appears to be overvalued.
The current stock price of €4.14 is trading 68.3% above its estimated GF Value™ of €2.46.
GuruFocus considers Clariane SE to be Significantly Overvalued.
Key valuation signals for FRA:KO2:
FCF Margin %: 19.30% (185% above median its 10-year median of 6.78)
GF Value™: €2.46 vs. price of €4.14 (68.3% above fair value)
Industry Position: 469.3% above the Healthcare Providers & Services median (#91 of 669)
No single metric tells the full story. See the FRA:KO2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Clariane SE is a specialist in non-acute care and operates in two main areas: long-term care, through two forms of support, medicalized nursing homes offering specialty facilities accommodation and care for vulnerable older people and alternative living solutions, and specialty care activities such as specialty and post-acute , mental health and a number of medical, surgical and obstetrics clinics. Its segments include France, Germany, Benelux, Italy and Spain.
61GF Score
Get the complete analysis for FRA:KO2
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:KO2 has been successfully added to your 
